Functionalization of ethylene vinyl acetate with antimicrobial chlorhexidine hexametaphosphate nanoparticles

International Journal of Nanomedicine

Volumn 9, Issue 1, 2014, Pages 4145-4152

  Wood, Natalie J ^a,b   Maddocks, Sarah E ^c   Grady, Helena J ^a,b   Collins, Andrew M ^b   Barbour, Michele E ^a  

^a Oral Nanoscience School of Oral and Dental Sciences   (United Kingdom)

^b UNIVERSITY OF BRISTOL   (United Kingdom)

^c CARDIFF METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Biomaterial; EVA; Polymer

Indexed keywords

CHLORHEXIDINE HEXAMETAPHOSPHATE NANOPARTICLE; ETHYLENE VINYL ACETATE COPOLYMER; NANOPARTICLE; UNCLASSIFIED DRUG; ANTIINFECTIVE AGENT; CHLORHEXIDINE; ETHYLENEVINYLACETATE COPOLYMER; HEXAMETAPHOSPHATE; PHOSPHATE; POLYVINYL DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ARTICLE; ATOMIC FORCE MICROSCOPY; BACTERIAL COLONIZATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFICACY; GROWTH INHIBITION; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PARTICLE SIZE; PSEUDOMONAS AERUGINOSA; SCANNING ELECTRON MICROSCOPY; SLOW DRUG RELEASE; TRANSMISSION ELECTRON MICROSCOPY; CHEMISTRY; DRUG EFFECT; MICROBIAL VIABILITY;

ANTI-BACTERIAL AGENTS; CHLORHEXIDINE; MICROBIAL VIABILITY; NANOPARTICLES; PHOSPHATES; POLYVINYLS; PSEUDOMONAS AERUGINOSA;

EID: 84924131106     PISSN: 11769114     EISSN: 11782013     Source Type: Journal    
DOI: 10.2147/IJN.S65343     Document Type: Article

References (28)

1. Christoforidis JB, Chang S, Jiang A, Wang J, Cebulla CM. Intravitreal devices for the treatment of vitreous inflammation. Mediators Inflamm. 2012;2012:126463.
2. Park JH, Cho YW, Cho YH, et al. Norfloxacin-releasing urethral catheter for long-term catheterization. J Biomater Sci Polym Ed. 2003;14(9): 951-962.
3. Cho YW, Park JH, Kim SH, et al. Gentamicin-releasing urethral catheter for short-term catheterization. J Biomater Sci Polym Ed. 2003;14(9): 963-972.
4. Bratlie KM, York RL, Invernale MA, Langer R, Anderson DG. Materials for diabetes therapeutics. Adv Healthc Mater. 2012;1(3):267-284.
5. Lete I, Cuesta MC, Marín JM, Guerra S. Vaginal health in contraceptive vaginal ring users - A review. Eur J Contracept Reprod Health Care. 2013;18(4):234-241.
6. Thurman AR, Clark MR, Hurlburt JA, Doncel GF. Intravaginal rings as delivery systems for microbicides and multipurpose prevention technologies. Int J Womens Health. 2013;5:695-708.
7. Kiser PF, Johnson TJ, Clark JT. State of the art in intravaginal ring technology for topical prophylaxis of HIV infection. AIDS Rev. 2012;14(1): 62-77.
8. Knapik JJ, Marshall SW, Lee RB, et al. Mouthguards in sport activities: history, physical properties and injury prevention effectiveness. Sports Med. 2007;37(2):117-144.
9. Dinato RC, Ribeiro AP, Butugan MK, Pereira IL, Onodera AN, Sacco IC. Biomechanical variables and perception of comfort in running shoes with different cushioning technologies. J Sci Med Sport. In press 2014.
10. Pasini Neto H, Grecco LA, Christovão TC, et al. Effect of posture-control insoles on function in children with cerebral palsy: randomized controlled clinical trial. BMC Musculoskelet Disord. 2012;13:193.
11. Helbling IM, Ibarra JC, Luna JA. The optimization of an intravaginal ring releasing progesterone using a mathematical model. Pharm Res. 2014;31(3):795-808.
12. Williamson JC, Virata SR, Raasch RH, Kylstra JA. Oxacillin-resistant Staphylococcus aureus endophthalmitis after ganciclovir intraocular implant. Am J Ophthalmol. 2000;129(4):554-555.
13. Shane TS, Martin DF; Endopthalmitis-Gancioclovir Implant Study Group. Endophthalmitis after ganciclovir implant in patients with AIDS and cytomegalovirus retinitis. Am J Ophthalmol. 2003;136(4): 649-654.
14. Charles NC, Freisberg L. Endophthalmitis associated with extrusion of a ganciclovir implant. Am J Ophthalmol. 2002;133(2):273-275.
15. Stickler DJ. Bacterial biofilms in patients with indwelling urinary catheters. Nat Clin Pract Urol. 2008;5(11):598-608.
16. Ogawa T, Yamasaki S, Honda M, Terao Y, Kawabata S, Maeda Y. Long-term survival of salivary streptococci on dental devices made of ethylene vinyl acetate. Int J Oral Sci. 2012;4(1):14-18.
17. Barbour ME, Maddocks SE, Wood NJ, Collins AM. Synthesis, characterization, and efficacy of antimicrobial chlorhexidine hexametaphosphate nanoparticles for applications in biomedical materials and consumer products. Int J Nanomedicine. 2013;8:3507-3519.
18. Barbour ME, O'Sullivan DJ, Jagger DC, Chlorhexidine adsorption to anatase and rutile titanium dioxide. Colloid Surface A. 2007;307(1-3): 116-120.
19. Miles AA, Misra SS, Irwin JO. The estimation of the bactericidal power of the blood. J Hyg (Lond). 1938;38(6):732-749.
20. Arnold RR, Wei HH, Simmons E, Tallury P, Barrow DA, Kalachandra S. Antimicrobial activity and local release characteristics of chlorhexidine diacetate loaded within the dental copolymer matrix, ethylene vinyl acetate. J Biomed Mater Res B Appl Biomater. 2008;86(2):506-513.
21. Tallury P, Alimohammadi N, Kalachandra S. Poly(ethylene-co-vinyl acetate) copolymer matrix for delivery of chlorhexidine and acyclovir drugs for use in the oral environment: effect of drug combination, copolymer composition and coating on the drug release rate. Dent Mater. 2007;23(4):404-409.
22. Lin DM, Kalachandra S, Valiyaparambil J, Offenbacher S. A polymeric device for delivery of anti-microbial and anti-fungal drugs in the oral environment: effect of temperature and medium on the rate of drug release. Dent Mater. 2003;19(7):589-596.
23. Nostro A, Scaffaro R, D'Arrigo M, et al. Development and characterization of essential oil component-based polymer films: a potential approach to reduce bacterial biofilm. Appl Microbiol Biotechnol. 2013; 97(21):9515-9523.
24. Pickard R, Lam T, MacLennan G, et al. Antimicrobial catheters for reduction of symptomatic urinary tract infection in adults requiring short-term catheterisation in hospital: a multicentre randomised controlled trial. Lancet. 2012;380(9857):1927-1935.
25. Shapur NK, Duvdevani M, Friedman M, et al. Sustained release varnish containing chlorhexidine for prevention of biofilm formation on urinary catheter surface: in vitro study. J Endourol. 2012;26(1):26-31.
26. Zelichenko G, Steinberg D, Lorber G, et al. Prevention of initial biofilm formation on ureteral stents using a sustained releasing varnish containing chlorhexidine: in vitro study. J Endourol. 2013;27(3):333-337.
27. Segev G, Bankirer T, Steinberg D, et al. Evaluation of urinary catheters coated with sustained-release varnish of chlorhexidine in mitigating biofilm formation on urinary catheters in dogs. J Vet Intern Med. 2013; 27(1):39-46.
28. Tenke P, Köves B, Johansen TE. An update on prevention and treatment of catheter-associated urinary tract infections. Curr Opin Infect Dis. 2014;27(1):102-107.